https://www.worldpharmatoday.com/clinical-trails/ose-immunotherapeutics-to-resume-accrual-in-phase-3-clinical-trial-of-tedopi-in-advanced-non-small-cell-lung-cancer-patients-following-immune-checkpoint-inhibitor-treatment/ Magazine for the C-level Pharma Executives Wed, 22 Nov 2017 10:39:10 +0000 hourly 1 https://wordpress.org/?v=6.9.4